Summary: Dental AI company Pearl raised $58 million in Series B funding led by Left Lane Capital, with participation from Smash Capital, Alpha Partners, Craft Ventures, and Neotribe Ventures. The funding will help expand Pearl’s dental AI products, regulatory and patent portfolio, and global access, aiming to improve diagnostic accuracy and patient care.

Key Takeaways:

  • Significant Funding: Pearl raised $58 million in Series B funding to enhance its dental AI products and expand its global reach.
  • AI-Driven Solutions: Pearl’s AI tools aid dentists in delivering diagnoses to improve patient care and communication.

Dental AI company Pearl announced that it has raised $58 million in Series B funding. Left Lane Capital led the round, with participation from Smash Capital, Alpha Partners, and existing investors, Craft Ventures and Neotribe Ventures.

Expansion and Development Plans

With this investment, Pearl will expand its line of dental AI products, broaden its regulatory and patent portfolio, and increase global access to AI in dentistry.

Pearl’s machine learning and computer vision tools aim to solve a core challenge in dentistry: inconsistency in diagnostic accuracy, which directly impacts the quality of patient care. The company’s AI serves as a real-time aid to help dentists read patient x-rays, deliver consistent, objective, and accurate diagnoses, and clearly communicate findings to patients.

Regulatory Milestones and Future Goals

Since receiving FDA clearance for AI software to help dental professionals detect multiple different pathologies and other conditions in x-rays, Pearl’s clinical AI has gained regulatory authorizations for chairside use in over 120 countries and was recognized in TIME’s Best Inventions. The company plans to use the funding to accelerate ongoing development of computer vision capabilities, including detection and tracking of disease in 3D and other imaging modalities, and introduce new AI tools to improve patient treatment planning, insurance claim approvals, and dental education.

“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care––and Pearl has led the AI charge in dentistry,” said Ophir Tanz, founder and chief executive officer of Pearl. “This historic funding round underscores the impact of Pearl’s capabilities and supports our belief that high-quality, AI-powered dental care should be accessible to everyone. With this investment, Pearl will continue to push the envelope, providing pioneering machine learning to improve oral health outcomes and strengthen trust between the patient and dental professionals.”

Pearl Details

According to the company, Pearl’s technology is used in dental practices across six continents and is commercially available worldwide. The company has also integrated its AI into dozens of imaging and practice management systems.

“We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation,” said Vinny Pujji, managing partner at Left Lane Capital. “Pearl’s pioneering dental AI improves diagnostic accuracy and efficiency while transforming the provider-patient relationship. We’re confident in Pearl’s ability to continue setting new standards of care and are thrilled to support their next phase of growth.”